Natasha Choukkar

Senior Manager, Portfolio Advisory Strategy Consulting at Evaluate

Speaker

Natasha is a Senior Manager in the consulting team, bringing over 12+ years of experience in pharma and life sciences strategy consulting, forecasting, competitive intelligence, and business development/licensing. She has worked with a diverse range of companies, from large pharma to small biotechs, across multiple geographies, advising on commercial strategy, portfolio management, competitive intelligence, and R&D strategic planning.

Before joining Evaluate, Natasha was associated with Prescient Healthcare Consulting, Merck, PharmACE, and Aragen Life Sciences (GVK BIO). Her experience spans various therapeutic areas, including oncology, hematology, CNS, rare diseases, vaccines and cell and gene therapy.

Her areas of expertise include competitive intelligence, clinical and commercial assessments, portfolio strategy, business development & licensing (BD&L), mergers & acquisitions (M&A), commercial due diligence, and strategic forecasting.

Natasha holds a Bachelor's degree in Chemistry and Biotechnology and a Master's in Business Administration.